Performance · Metabolic research

retatrutide

FAT LOSS · APPETITE CONTROL · METABOLISM

research overview

Retatrutide is a triple-agonist compound currently under clinical investigation. Research has focused on GLP-1, GIP and glucagon pathways and their relationship to appetite regulation, metabolism and body-weight outcomes.

For research purposes only. The catalogue information is not medical advice.

← BACK TO RESEARCH CATALOGUE